Literature DB >> 25392012

Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination.

Jiangping Ren1, Linong Yao1, Jimin Sun1, Zhenyu Gong2.   

Abstract

The Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination, was developed by I. Vodopija and colleagues of the Zagreb Institute of Public Health in Croatia in the 1980s. It was recommended by WHO as one of the intramuscular (IM) schedules for rabies vaccination in 2010. We reviewed the literature on the immunogenicity, safety, economic burden, and compliance of the Zagreb 2-1-1 regimen. Compared to Essen, another IM schedule recommended by WHO, Zagreb has higher compliance, lower medical cost, and better immunogenicity at an early stage.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Mesh:

Substances:

Year:  2014        PMID: 25392012      PMCID: PMC4278924          DOI: 10.1128/CVI.00531-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

1.  Rabipur: a reliable vaccine for rabies protection.

Authors:  I Vodopija; Z Baklaić; R Vodopija
Journal:  Vaccine       Date:  1999-03-26       Impact factor: 3.641

2.  The real cost of rabies post-exposure treatments.

Authors:  Amlan Goswami; Juliette Plun-Favreau; Nicolas Nicoloyannis; Gadey Sampath; Mohd N Siddiqui; Jean-Antoine Zinsou
Journal:  Vaccine       Date:  2005-04-27       Impact factor: 3.641

3.  One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine.

Authors:  S Chutivongse; H Wilde; D B Fishbein; G M Baer; T Hemachudha
Journal:  Vaccine       Date:  1991-08       Impact factor: 3.641

4.  Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.

Authors:  J Lang; G H Simanjuntak; S Soerjosembodo; C Koesharyono
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

5.  Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine.

Authors:  R Vodopija; M Lafont; Z Baklaić; M Ljubicić; M Svjetlicić; I Vodopija
Journal:  Vaccine       Date:  1997-04       Impact factor: 3.641

6.  Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China.

Authors:  Quan Hu; Man-Qing Liu; Zheng-Gang Zhu; Ze-Rong Zhu; Sha Lu
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 7.  Re-evaluating the burden of rabies in Africa and Asia.

Authors:  Darryn L Knobel; Sarah Cleaveland; Paul G Coleman; Eric M Fèvre; Martin I Meltzer; M Elizabeth G Miranda; Alexandra Shaw; Jakob Zinsstag; François-Xavier Meslin
Journal:  Bull World Health Organ       Date:  2005-06-24       Impact factor: 9.408

8.  An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule.

Authors:  I Vodopija; P Sureau; M Lafon; Z Baklaic; M Ljubicić; M Svjetlicić; S Smerdel
Journal:  Vaccine       Date:  1986-12       Impact factor: 3.641

9.  Studies on human anti-rabies immunization in Brazil. II--Preliminary evaluation of the 2-1-1 schedule for human pre-exposure anti-rabies immunization, employing suckling mouse brain vaccine.

Authors:  C R Zanetti; L M Lee; L B Chaves; J L Rodrigues; G C Eleutério; O A Pereira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1995 Jul-Aug       Impact factor: 1.846

10.  Do anaesthetics and surgical stress increase the risk of post-exposure rabies treatment failure?

Authors:  R Fescharek; V Franke; M R Samuel
Journal:  Vaccine       Date:  1994-01       Impact factor: 3.641

View more
  6 in total

Review 1.  Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies.

Authors:  Charles Rupprecht; Ivan Kuzmin; Francois Meslin
Journal:  F1000Res       Date:  2017-02-23

2.  Rabies Vaccination Compliance and Reasons for Incompletion.

Authors:  Tony Shi; Eleanor F Dunham; Jennifer E Nyland
Journal:  West J Emerg Med       Date:  2020-07-02

3.  Benefit-cost analysis of the policy of mandatory annual rabies vaccination of domestic dogs in rabies-free Japan.

Authors:  Nigel C L Kwan; Akio Yamada; Katsuaki Sugiura
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

4.  Modelling to inform prophylaxis regimens to prevent human rabies.

Authors:  Katie Hampson; Bernadette Abela-Ridder; Omesh Bharti; Lea Knopf; Monique Léchenne; Rolande Mindekem; Arnaud Tarantola; Jakob Zinsstag; Caroline Trotter
Journal:  Vaccine       Date:  2018-12-07       Impact factor: 4.169

Review 5.  Rabies mortality and morbidity associated with animal bites in Africa: a case for integrated rabies disease surveillance, prevention and control: a scoping review.

Authors:  Peter Suwirakwenda Nyasulu; Jacqueline Weyer; Rea Tschopp; Adane Mihret; Abraham Aseffa; Samuel Victor Nuvor; Jacques Lukenze Tamuzi; Luke Nyakarahuka; Gideon Kofi Helegbe; Nyanda Elias Ntinginya; Melaku Tefera Gebreyesus; Seydou Doumbia; Reinhard Busse; Christian Drosten
Journal:  BMJ Open       Date:  2021-12-02       Impact factor: 2.692

6.  Improving systematic rabies surveillance in Cameroon: A pilot initiative and results for 2014-2016.

Authors:  Casimir Ledoux Sofeu; Anaïs Broban; Amadou Njifou Njimah; Jean Blaise Momo; Serge Alain Sadeuh-Mba; Sophie Druelles; Maïna L'Azou; Mathurin Cyrille Tejiokem
Journal:  PLoS Negl Trop Dis       Date:  2018-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.